ClinicalTrials.Veeva

Menu

Hemogram Parameter Changes With Sepsis Filter

S

Samsun University

Status

Completed

Conditions

Immune System Disorder
Renal Failure
Platelet Abnormality

Study type

Observational

Funder types

Other

Identifiers

NCT06948630
Istinye University

Details and patient eligibility

About

Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.

Enrollment

92 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Data of patients who were monitored in the Intensive Care between January 2020 and December 2022 and who were applied sepsis filters

Exclusion criteria

  • -Patients who underwent hemodiafiltration with sepsis filter but could not be followed for 72 hours (death, etc.)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems